| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |